| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.005 |